Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Ophthalmology

 

HBI 2026: Investing in the UK and Ireland

A panel entitled ‘Investing in the UK and Ireland’ at HBI’s 2026 conference discussed how the healthcare market in the UK and Ireland is being shaped by policy shifts, which include the latest 10-year plan from the National Health Service (NHS). 
May 7, 2026

What Europe can learn from Asia’s high-volume ophthalmology models — in conversation with Carl Zeiss Meditec

Ahead of the Ophthalmology Community Summit at HBI 2026 in partnership with Carl Zeiss Meditec, HBI speaks to Ana Neves, Head of Global Strategic Marketing, and Michael Achtelik, Managing Director of Carl Zeiss Meditec about how digital workflows, interoperability and AI are influencing the development of ophthalmic care, and what Europe may be able to learn from developments in Asia, and vice versa.
March 12, 2026

MidEuropa buys wheelchair CDMO and Croatian opticians’ chain

Central European private equity firm MidEuropa has acquired MBL Group, Europe’s largest contract research and development organisation (CDMO) focused on assisted mobility devices, and has also acquired Optika Anda, Croatia’s largest optical retail chain.
January 8, 2026

Verlinvest invests $75m in The Eye Foundation

Verlinvest, the Belgium-based family investment firm, has invested $75 million for a minority stake in The Eye Foundation, an Indian ophthalmology chain with more than 25 hospitals across southern India.
October 30, 2025

Indian eyewear retailer Lenskart targets $960 million IPO

The south Asian country’s healthcare and consumer tech sectors are seeing a surge in IPOs, reflecting strong investor confidence. For European investors, India offers selective opportunities in diagnostics, specialty hospitals, medtech, and senior care, promising high returns when paired with experienced local partners.
October 16, 2025

Alcon to acquire STAAR Surgical for US $1.5bn

Alcon’s planned purchase of STAAR Surgical adds the latter’s EVO ICL lens technology to its refractive surgery portfolio, aiming to broaden treatment options for myopia and strengthen its position in a market seeing significant deal activity.
August 14, 2025
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us